BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15389554)

  • 1. Regulation of the human organic cation transporter hOCT1.
    Ciarimboli G; Struwe K; Arndt P; Gorboulev V; Koepsell H; Schlatter E; Hirsch JR
    J Cell Physiol; 2004 Dec; 201(3):420-8. PubMed ID: 15389554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
    Zhang L; Schaner ME; Giacomini KM
    J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation.
    Ciarimboli G; Koepsell H; Iordanova M; Gorboulev V; Dürner B; Lang D; Edemir B; Schröter R; Van Le T; Schlatter E
    J Am Soc Nephrol; 2005 Jun; 16(6):1562-70. PubMed ID: 15829703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases.
    Cetinkaya I; Ciarimboli G; Yalçinkaya G; Mehrens T; Velic A; Hirsch JR; Gorboulev V; Koepsell H; Schlatter E
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F293-302. PubMed ID: 12388397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP.
    Schlatter E; Mönnich V; Cetinkaya I; Mehrens T; Ciarimboli G; Hirsch JR; Popp C; Koepsell H
    J Membr Biol; 2002 Oct; 189(3):237-44. PubMed ID: 12395288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
    Kimura N; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
    Bourdet DL; Pritchard JB; Thakker DR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.
    Zhang L; Gorset W; Dresser MJ; Giacomini KM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1192-8. PubMed ID: 10027858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
    Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
    Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters.
    Kang HJ; Lee SS; Lee CH; Shim JC; Shin HJ; Liu KH; Yoo MA; Shin JG
    Drug Metab Dispos; 2006 Jul; 34(7):1145-51. PubMed ID: 16624869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin.
    Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS
    Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
    Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of organic cation transport in IHKE-1 and LLC-PK1 cells. Fluorometric studies with 4-(4-dimethylaminostyryl)-N-methylpyridinium.
    Hohage H; Stachon A; Feidt C; Hirsch JR; Schlatter E
    J Pharmacol Exp Ther; 1998 Jul; 286(1):305-10. PubMed ID: 9655873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha.
    Saborowski M; Kullak-Ublick GA; Eloranta JJ
    J Pharmacol Exp Ther; 2006 May; 317(2):778-85. PubMed ID: 16436500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
    Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
    Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity.
    Tu M; Sun S; Wang K; Peng X; Wang R; Li L; Zeng S; Zhou H; Jiang H
    Toxicology; 2013 Sep; 311(3):225-30. PubMed ID: 23831208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and regulation of organic cation transport in freshly isolated human proximal tubules.
    Pietig G; Mehrens T; Hirsch JR; Cetinkaya I; Piechota H; Schlatter E
    J Biol Chem; 2001 Sep; 276(36):33741-6. PubMed ID: 11447227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes.
    Sogame Y; Kitamura A; Yabuki M; Komuro S
    Biopharm Drug Dispos; 2009 Nov; 30(8):476-84. PubMed ID: 19768675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of an immobilized human organic cation transporter based liquid chromatographic stationary phase.
    Moaddel R; Yamaguchi R; Ho PC; Patel S; Hsu CP; Subrahmanyam V; Wainer IW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):263-8. PubMed ID: 15734168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
    Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.